UPC_CFI_146/2024

NOVEL ANTITUMORAL USE OF CABAZITAXEL

InfringementMain Infringement ActionMunich LDInfringementCase Closed

This case cites

Authorities cited within the decisions on file for this case.

Target	Legal point	Strength	Excerpt
RoP_rule 353	rectification of decisions and orders	Binding	Application pursuant to Rule 353 – Rectification of decisions and orders
RoP_rule 334	outstanding applications no longer need adjudication when infringement action dismissed	Binding	As the infringement actions are dismissed, any other outstanding applications and requests relating to them no longer need to be adjudicated (R. 334 RoP).
RoP_rule 30	auxiliary requests for patent amendment	Binding	Sanofi did not file an application pursuant to Rule 30 of the Rules of procedure. Therefore, no auxiliary requests must be considered.

Target	Legal point	Strength	Excerpt
Art. 73 UPCA	appeal rights; time limit	Binding	An appeal against the present Decision may be lodged at the Court of Appeal, by any party which has been unsuccessful, in whole or in part, in its submissions, within two months of the date of its notification (Art. 73(1) UPCA

Cited by

Subsequent UPC decisions citing this case.

Not yet cited in another decision in our corpus.